L VAD Technology, Inc.is a firm company dedicated to the research and development of mechanical systems for treating heart failure. The company has developed the CardioPlus Device. CardioPlus functions like the intraaortic balloon pump, for 30 years, the gold standard for hospital treatment of acute heart failure. The CardioPlus is more powerful than the balloon pump and allows the CHF patient to live at home and resume many normal activities. The device contains only 2 implanted components: 1) A one ounce, 5", 60cc pump implanted in the aorta, has no valves, inflates and deflates using room air. and 2) A proprietary connector, precovered with patients own skin cells to promote stability, allowing detachment from the drive unit. The drive unit is external, detachable, and readily replaceable. One version is battery-powered, weighs 5 pounds and is worn in a vest. The other looks like carry-on luggage, has wheels and uses house current. CardioPlus simple, elegant design has demonstrated it can: Improve advanced heart failure patients by at least one functional class, relieve symptons of CHF, reduce or eliminate need for Inotropic medications. Be turned on and off with a simple switch without risk of emboli, without use of anticoagulants.